[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2013143599A1 - Devices and methods for the treatment of metabolic disorders. - Google Patents

Devices and methods for the treatment of metabolic disorders. Download PDF

Info

Publication number
WO2013143599A1
WO2013143599A1 PCT/EP2012/055795 EP2012055795W WO2013143599A1 WO 2013143599 A1 WO2013143599 A1 WO 2013143599A1 EP 2012055795 W EP2012055795 W EP 2012055795W WO 2013143599 A1 WO2013143599 A1 WO 2013143599A1
Authority
WO
WIPO (PCT)
Prior art keywords
stimulus
electrodes
electrical
pulse generator
subject
Prior art date
Application number
PCT/EP2012/055795
Other languages
French (fr)
Inventor
Kevin D. Felder
Gary L. Long
Mark Steven Ortiz
Alessandro Pastorelli
Michele D'arcangelo
Toralf Bork
Rocco Crivelli
Mathilde MIGURAS
Martin Pfleiderer
Yanik S. TARDY
Original Assignee
Ethicon Endo-Surgery, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Endo-Surgery, Inc. filed Critical Ethicon Endo-Surgery, Inc.
Priority to PCT/EP2012/055795 priority Critical patent/WO2013143599A1/en
Publication of WO2013143599A1 publication Critical patent/WO2013143599A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36067Movement disorders, e.g. tremor or Parkinson disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0507Electrodes for the digestive system
    • A61N1/0509Stomach and intestinal electrodes

Definitions

  • the present invention relates generally to devices and methods for the treatment of metabolic disorders using stimulation of the gastrointestinal tract. More specifically, the present invention relates to devices and methods for stimulating the intestine in order to trigger metabolic effects. The present invention further relates to a combined system for meal detection and stimulation of the small intestine (duodenum, jejunum or ileum) aiming at an increased secretion of endogenous GLP-1 during meal intake.
  • GLP-1 Glucagon-Like Peptide
  • the hormones produce this effect by inducing a sense of fullness and cessation of eating (satiety), triggering the release of insulin to maintain proper glucose levels (incretin effect) and slowing the passage of contents through the digestive tract (delaying gastric emptying and slowing small intestinal transit).
  • these effects have been referred to as the "ileal brake" mechanism which involves both the hormones that play a role (such as PYY, GLP-1 , and GLP-2, among others), as well as the multiplicity of effects of release of those hormones (gastric emptying, a feeling of fullness cessation of eating, triggering of insulin secretion).
  • An insufficient ileal brake i .e. , the inability of the body to release sufficient quantities of these hormones in response to a meal, is a contributory factor in obesity and Type 2 Diabetes. While in non-obese non-diabetic individuals fasting levels of GLP-1 are observed to be in the range of 5-10 pmol/L and to increase rapidly to 15-50 pmol/L after a meal, in T2D patients, the meal-related increase in GLP-1 is significantly less. The decreased insulin levels of such patients are attributable to an insufficient level of GLP-1. Similarly, also in obese subjects lower basal fasting hormone levels and smaller meal- associated rise of the hormone levels have been observed. Therefore, enhancing the body's endogenous levels of GLP-1 is believed to have impact on both obesity and diabetes.
  • DPP-4 dipeptidyl peptidase-4
  • vildagliptin dipeptidyl peptidase-4
  • improvement in glucose control is obtained by increasing the circulating levels of GLP-1 by vildagliptin.
  • US2010/0056948 describes a method of stimulating the release of satiety hormones in a subject comprising applying an electrical stimulus to a tissue in the gastrointestinal system of the subject contemporaneously with the contacting of L-cells of the tissue with a nutrient stimulus.
  • a method of stimulating the release of satiety hormone in a subject, the method comprising applying one of an electrical and electromagnetic stimulus to a tissue of a gastrointestinal system of the subject and time dependency changing the location of application of the stimulus at the tissue.
  • a system for stimulating the release of satiety hormone in a subject comprises a stimulus device having an electrical pulse generator and stimulus electrodes adapted to apply an electrical stimulus to a tissue, the stimulus device being configured to time dependency move at least one of the stimulus electrodes for time-dependently changing the location of application of the stimulus.
  • a method of stimulating the release of satiety hormone in a subject comprising providing an electrical stimulus device having an electrical pulse generator and electrical stimulus electrodes, transporting the electrical stimulus device endoluminally to a target location in a gastrointestinal system of the subject, anchoring the stimulus device in the target location such that the stimulus electrodes engage a tissue of the gastrointestinal system, and applying an electrical stimulus to the tissue by means of the stimulus device.
  • a system for stimulating the release of satiety hormone in a subject, the system comprising a stimulus device having an electrical pulse generator and stimulus electrodes adapted to apply an electrical stimulus to a tissue, the stimulus device being adapted to be endoluminally introduced in a gastrointestinal system of the subject, the system further comprising means for permanently anchoring the stimulus device in a target location inside the gastrointestinal system i n a positi on i n which the sti m u l us el ectrodes engage a tissue of the gastrointestinal system at the target location.
  • a method of stimulating the release of satiety hormone in a subject comprises providing an electrical stimulus device having an electrical pulse generator and electrical stimulus electrodes, placing the stimulus device in an abdominal space of the subject at the outside of a target lumen of intestine, anchoring the stimulus device at the target lumen such that the stimulus electrodes engage a tissue of the target lumen from outside the target lumen, and applying an electrical stimulus to the tissue by means of the stimulus device.
  • a system for stimulating the release of satiety hormone in a subject comprises a stimulus band configured to be deformable from an open shape to a closed ring shape and lockable in the closed ring shape, multiple stimulation electrodes arranged at the stimulus band such that they can contact a section of small intestine when the stimulus band is placed from outside around said section of small intestine, an electrical pulse generator arranged at the stimulus band and operable to energize the stimulus electrodes.
  • the method comprises continuously monitoring at least one characteristic of the subject to detect an ingestion of food by the subject, and applying the electrical or electromagnetic stimulus to the gastrointestinal system in response to a detected ingestion of food.
  • the proposed system comprises a detection device which is implantable in the subject and adapted to continuously monitoring at least one of a mechanical characteristic and an electrical characteristic of the subject to detect an ingestion of food by the subject, and the detection device cooperates with the stimulus device such that the stimulus device applies the electrical stimulus in response to a detected ingestion of food.
  • FIG. 1 shows a schematic block diagram of a meal detection and electrical stimulation system for stimulating the release of satiety hormones in accordance with an embodiment
  • FIG. 2 illustrates a first embodiment of an electrical stimulation system for stimulating the release of satiety hormones, the system being endoluminally implanted in a Gl tract;
  • FIG. 3 illustrates a second embodiment of an electrical stimulation system for stimulating the release of satiety hormones, the system being endoluminally implanted in a Gl tract;
  • FIG. 4 illustrates a third embodiment of an electrical stimulation system for stimulating the release of satiety hormones, the system being endoluminally implanted in a Gl tract;
  • FIG. 5 through 10 illustrate further embodiments of an electrical stimulation system for stimulating the release of satiety hormones, the systems being endoluminally implanted in a Gl tract;
  • FIG. 1 1 illustrates an embodiment of an electrical stimulation system for stimulating the release of satiety hormones, the system having a stimulus band laparoscopically inserted in an abdominal space placed around a lumen of a Gl tract;
  • FIG. 12 shows the stimulus band of figure 1 1 in a frontal view and in a longitudinal section
  • FIG. 13 illustrates a further embodiment of an electrical stimulation system for stimulating the release of satiety hormones, the system being endoluminally placed in a section of the ileum and in a section of colon of a patient;
  • FIG. 14 and 15 illustrate electrical stimulation systems in accordance with further exemplary embodiments
  • FIGS. 16 and 17 are schematic illustrations of an electrical stimulation system for stimulating the release of satiety hormones in accordance with embodiments, in which the location of stimulation can be varied over time;
  • FIG. 18 illustrates a further embodiment of an electrical stimulation system for stimulating the release of satiety hormones
  • FIG. 19 illustrates a yet further embodiment of an electrical stimulation system for stimulating the release of satiety hormones
  • FIG. 20 illustrates a detail of an electrical stimulation device for stimulating the release of satiety hormones, in accordance with an embodiment
  • FIG. 21 illustrates an adhesive patch electromagnetic stimulation device in accordance with an embodiment
  • FIG. 22 shows a method of stimulating the release of satiety hormones involving an extracorporeal application of adhesive patch stimulating devices of figure 21 ;
  • FIG. 23 shows a method for stimulating the release of satiety hormones involving stimulation devices of the invention
  • FIG. 24 shows a method and devices for stimulating the release of satiety hormones in accordance with a further embodiment
  • Figure 25A illustrates an extracorporeal adhesive magnetic patch for holding the swallowable pill of figure 25 in a planned position in a Gl tract
  • FIG. 28A, 28B, 28C, 28D illustrate electrode movement devices in accordance with embodiments of the invention.
  • a method of stimulating the release of satiety hormone in a subject comprises:
  • the entire stimulation system may be controlled by a control unit 4 (a microchip with a memory, a battery, and a data acquisition and elaboration software) which may be onboard the stimulus device 1 or remote from the stimulus device 1 and in signal communication (by conductive wire or wireless, e.g. by an RF transmitter-receiver communication channel) with the electrical pulse generator 2 and adapted to control the electrical pulse generator 2 in accordance with a preset stimulation program and or in dependency of signals received from an external controller 44 ( Figure 23) or from food detection sensors 5, 6.
  • the control unit 4 may be adapted to elaborate the signals received from the food detection sensors (e.g. pressure sensors 5, electrical activity sensors 6, pH meter 7, glucose level sensor 8) to identify a condition of food intake and, in response to the identified condition of food intake, to generate a stimulus signal and provide the stimulus signal to the electrical pulse generator 2.
  • the food detection sensors e.g. pressure sensors 5, electrical activity sensors 6, pH meter 7, glucose level sensor 8
  • the food detection sensors may be linked by a signal communication line (by conductive wire or wireless, e.g. by an RF transmitter-receiver communication channel) to the control unit 4.
  • a signal communication line by conductive wire or wireless, e.g. by an RF transmitter-receiver communication channel
  • the stimulus electrodes 3 are linked to the electrical pulse generator 2 and adapted to apply an electrical stimulus to a tissue.
  • the stimulus device 1 itself is adapted to be endoluminally introduced (e.g. transorally or transanally) in the gastrointestinal system of the patient, and means are provided for permanently anchoring the stimulus device 1 in a target location inside the gastrointestinal system.
  • the anchoring means may comprise an expandable balloon shaped or coil shaped anchoring body 9 which is endoluminally inserted inside a stomach 10 of the patient and then expanded to hold itself inside the stomach 10.
  • Food detecting sensors such as a pressure sensor 5 and/or a pH meter 7 and/or a pair of detecting electrodes 6 may be arranged on the anchoring body 9 so that after placement of the anchoring body 9, at least one of a pressure, pH and electrical current in the gastric wall can be monitored by the food detecting sensors and transmitted to the control unit 4.
  • the control unit 4 and the pulse generator 2 are also received in the anchoring body 9 and one or more pairs of stimulus electrodes 3 are provided at a distance from the anchoring body 9 and connected by electrical wires 1 1 to the pulse generator 2, so that the wires 1 1 can extend from the anchoring body 9 which is placed inside the stomach 10 through the pylorus 12 down into the small intestine (ad es. duodenum 13) where the stimulus electrodes 3 engage and electrically stimulate an intestinal mucosa to produce endogenous GLP-1.
  • the electrical wires 1 1 (which can be united in one single wire bundle) accomplish both electrical energizing and pull resistant mechanical connection of the electrodes 3 to the anchoring body 9.
  • the stimulus electrodes 3 may comprise plate like electrode pads ( Figure 8) with or without an adhesive layer for a reliable attachment to the intestinal mucosa, coiled electrode arrangements ( Figures 5, 7) or metal mesh stent arrangements ( Figure 6) adapted to be expanded from an initially compacted shape to a radially expanded shape for engaging the intestinal wall by contact pressure, or corkscrew shaped electrode arrangements adapted to be screwed into an intestinal mucosa (Figure 9).
  • the stimulus electrodes 3 may be elastically held in contact with the tissue by means of an elastic spring attached thereto, e.g. a Nitinol spring, or a flexible elastomeric sponge (Figure 18) which can also elastically follow peristalsis movements of the intestine.
  • the electrical pulse generator 2 is connected to an RF transmitter circuit and antennae 14 for a wireless transmission of the electrical stimulation energy and signals
  • the electrode 3 arrangement comprises an RF receiving circuit and antenna 15 for a wireless reception of the stimulation energy and signals (a wireless transmission of the stimulating energy can be obviated by providing the stimulus electrode arrangement 3 with an onboard power source or battery).
  • the wires 1 1 are not necessary, however, the electrode 3 arrangement must be directly anchored inside the small intestine ( Figure 6) or connected to the anchoring body 9 by means of a tether 18 ( Figure 6).
  • the anchoring means comprise a proximal annular flange 16 (forming the above said anchoring body 9) which may be rigid or expandable from an initially collapsed shape which allows endoluminal insertion thereof into the stomach 10 to an expanded shape which allows the proximal flange 16 to be seated in the antrum of the stomach without migrating distally through the pylorus.
  • the anchoring means further comprise a distal annular flange 17 which may be rigid or expandable from an initially collapsed shape which allows endoluminal insertion thereof into the duodenum 13 to an expanded shape which allows the distal flange 17 to be seated in the proximal duodenum without migrating proximally through the pylorus back into the stomach.
  • the proximal and distal flanges 16, 17 are connected to each other by a pull resistant tether 18 adapted to flexibly extend through the pylorus, such that the flanges 16, 17 hold the pylorus between them.
  • food detecting sensors such as a pressure sensor 5 and/or a pH meter 7 and/or a pair of detecting electrodes 6, the control unit 4 and the pulse generator 2 may be arranged in the proximal flange 16 and one or more pairs of stimulus electrodes 3 are provided at or connected to the distal flange 17 in intimate contact with the intestinal wall for electrically stimulating the mucosa to produce endogenous GLP-1.
  • the stimulus electrodes 3 may be connected by electrical wires to the pulse generator 2 at the proximal flange 16, so that the electrical wires (which can be united in one single wire bundle) accomplish both electrical connection and pull resistant mechanical tethering between the two flanges 16, 17.
  • the stimulus electrodes 3 may comprise plate like electrode pads ( Figure 8) with or without an adhesive layer for a reliable attachment to the intestinal mucosa, coiled electrode arrangements ( Figures 5, 7) or metal mesh stent arrangements ( Figure 6) adapted to be expanded from an initially compacted shape to a radially expanded shape for engaging the intestinal wall by contact pressure, or corkscrew shaped electrode arrangements adapted to be screwed into an intestinal mucosa (Figure 9).
  • the stimulus electrodes 3 may be elastically held in contact with the tissue by means of an elastic spring attached thereto, e.g. a Nitinol spring, or a flexible elastomeric sponge (Figure 18) which can also elastically follow peristalsis movements of the intestine.
  • the electrical pulse generator 2 is connected to an RF transmitter circuit and antennae 14 at the proximal flange 16 for a wireless transmission of the electrical stimulation energy and signals
  • the electrode 3 arrangement comprises an RF receiving circuit and antenna 15 (preferably at the distal flange 17) for a wireless reception of the stimulation energy and signals.
  • the anchoring means comprise an expandable colonic stent 20 which is endoluminally placed and expanded within a colon 19 of the patient.
  • the control unit 4 and the pulse generator 2 may be connected to or received inside the colonic stent 20 and one or more pairs of stimulus electrodes 3 are arranged at a distance from the colonic stent 20 and adapted to intimately engage an ileal mucosa from inside an ileum 21 of the patient for electrically stimulating the ileal mucosa to produce endogenous GLP-1.
  • the stimulus electrodes 3 may be connected by electrical wires to the pulse generator 2 at the colonic stent 20 ( Figure 15).
  • the electrical pulse generator 2 is connected to an RF transm itter circuit and antennae 14 at the colonic stent 20 for a wi reless transmission of the electrical stimulation energy and signals
  • the electrode 3 arrangement comprises an RF receiving circuit and antenna 15 for a wireless reception of the stimulation energy and signals (a wireless transmission of the stimulating energy can be obviated by providing the stimulus electrode arrangement 3 with an onboard power source or battery).
  • the control unit 4 can be further connected to a RF receiver for a wireless reception of food detection signals.
  • the stimulus electrodes 3 may comprise plate like electrode pads with or without an adhesive layer for a reliable attachment to the intestinal mucosa, coiled electrode arrangements ( Figures 13, 14, 1 5) or metal mesh stent arrangements adapted to be expanded from an initially compacted shape to a radially expanded shape for engaging the intestinal wall by contact pressure, or corkscrew shaped electrode arrangements adapted to be screwed into an intestinal mucosa.
  • the stimulus electrodes 3 may be elastically held in contact with the tissue by means of an elastic spring attached thereto, e.g. a Nitinol spring, or a flexible elastomeric sponge (Figure 18) which can also elastically follow peristalsis movements of the intestine.
  • the stimulus electrodes 3 may comprise a metal mesh stent arrangement adapted to be expanded from an initially compacted shape to a radially expanded shape for engaging the intestinal wall by contact pressure, wherein however the electrical pulse generator 2 is directly arranged onboard the electrode stent ( Figure 7) and not carried by the anchoring means as in the previously described embodiments.
  • a metal mesh stent stimulus electrode 3 arrangement contemplated by the invention may comprise two non-isolated electrically conductive paths 22, 23 that are arranged to one another in an overlapping manner and that are expandable from a first collapsed shape (adapted for endoscopic insertion) to a second expanded shape (adapted to engage the intestinal mucosa), both paths 22, 23 being isolated from each other at each overlapping point, e.g. by means of an isolating component 24 defining a hinge between both conductive paths 22, 23 ( Figure 7).
  • the stimulus electrodes 3 may be arranged on an external surface of an endoluminal, e.g. duodenal, flexible sleeve 25 which is connected to the anchoring means (expandable gastric anchoring body 9, balloon, coil, flanges 16, 17) by a tether 18 or by electrical wire 1 1 acting both as electrical conductor and as tether.
  • an endoluminal e.g. duodenal, flexible sleeve 25 which is connected to the anchoring means (expandable gastric anchoring body 9, balloon, coil, flanges 16, 17) by a tether 18 or by electrical wire 1 1 acting both as electrical conductor and as tether.
  • the stimulus electrodes 3 may be arranged on an external surface of an endoluminal bile diverting sleeve 25' which has a proximal end portion 35 inserted inside the biliary tree 34 and a distal portion 36 extended inside the duodenum 13.
  • the sleeve 25' may be anchored against undesired distal migration in the biliary tree or in the duodenum or in the stomach.
  • the stimulus electrodes 3 may be arranged in discrete positions or continuous conductive paths anywhere on the sleeve 25'.
  • the electrical stimulus device 1 may comprise an orally swallowable pill 37 which is orally administered to the patient and adapted to travel endoluminally to a target section of the gastrointestinal system.
  • Food detecting sensors such as a pressure sensor 5 and/or a pH meter 7 and/or a pair of detecting electrodes 6 may be arranged on the pill 37 so that, after placement of the pill 37, at least one of a pressure, pH or electrical current in the intestinal wall can be monitored by the food detecting sensors and transmitted to the control unit 4.
  • control unit 4 and the pulse generator 2 are also received in the pill 37 and one or more pairs of stimulus electrodes 3 are supported by the pill 37 and electrically connected to the pulse generator 2 such that they can engage and electrically stimulate an intestinal mucosa to produce endogenous GLP-1.
  • the system may further comprise magnetic anchoring means, such as an extracorporeal belt or adhesive patch 42 ( Figure 25A) which can be fastened to the patient or an anchoring band adapted to be applied from outside around the target section of intestinal lumen.
  • These anchoring means have a permanent magnetic or electromagnetic field source 38 adapted to cooperate with an onboard magnet 39 housed in the swallowable pill 37 to block the swallowable pill 37 in place, e.g. in the duodenum 13 or ileum 21.
  • Alternative or additional mechanical anchoring means may include a temperature sensitive shape memory anchor 40 connected to the pill 37 and adapted to deform from a collapsed shape (broken line in Figures 26, 27, adapted for endoluminal transit) to an expanded shape (solid line in Figures 26, 27, adapted for anchoring).
  • the pill may comprise a heater, e.g. an electric resistance 41 , arranged in heat exchanging relationship with the shape memory anchor 40 and energized by the control unit 4.
  • the shape memory anchor 40 may have:
  • the anchor 40 may form a coiled tail (Figure 27) extending axially and radially away from the pill, or
  • the stimulus electrodes 3 may be supported by the shape memory anchor 40 to intimately engage the intestinal mucosa.
  • a method of stimulating the release of satiety hormone in a subject comprises:
  • the stimulus device 1 may comprise a stimulus band 26 configured to be deformable from an open shape to a closed ring shape and lockable in the closed ring shape, multiple stimulation electrodes 3 arranged at the stimulus band 26 such that they can contact a section of small intestine when the stimulus band 26 is placed from outside around the section of small intestine, and an electrical pulse generator 2 arranged at the stimulus band 26 and operable to energize the stimulus electrodes 3.
  • the stimulus electrodes 3 may be provided on a radially internal surface of the stimulus band 26 to engage the intestine, e.g. the duodenum 13 from outside. Moreover a ridge 27 can be formed on the internal surface of the stimulus band 26 in a direction that the ridge 27 circumferentially engages the intestinal lumen around which the stimulus band 26 is fastened and prevents undesired displacement of the stimulus band 26 along the lumen.
  • Placement of the stimulus band 26 may be effected by open surgery or by laparoscopy, but also by endolumenal transportation of the band 26 to the desired site for stimulating the production of GLP-1 , translumenal placement of the band 26 from inside the intestine through an incision in the lumen wall to its outside and extension of the band from outside the lumen around the lumen.
  • the pulse generator 2 can be activated to apply the electrical stimulus from the outside to the tissue.
  • both the control unit 4 and the pulse generator 2 may be connected to or received inside the stimulus band 26 and the stimulus electrodes 3 may be connected by electrical wires to the pulse generator 2.
  • the control unit 4 and/or the electrical pulse generator 2 (onboard the stimulus band 26 or remote from the stimulus band 2 is connected to an RF transmitter circuit and antennae for a wireless transmission of the electrical stimulation energy and/or signals, and the stimulus electrodes 3 at the band 26 are linked to an RF receiving circuit and antenna for a wireless reception of the stimulation energy and/or signals (a wireless transmission of the stimulating energy can be obviated by providing an onboard power source or battery in the stimulus band 26).
  • the control unit 4 can be further connected to a RF receiver for a wireless reception of food detection signals.
  • a method of stimulating the release of satiety hormone in a patient, the method comprising applying one of an electrical and electromagnetic stimulus to a tissue of a gastrointestinal system of the subject and time dependently changing the location of application of the stimulus at the tissue.
  • a time- dependent change or variation of the location of application of the electrical stimulus may be desirable to optimize the treatment or maximize the release of GLP-1 , as well as to reducing a risk of tissue trauma (by burning) due to a continued electric stimulus.
  • the method can be implemented by means of a stimulus device 1 which is configured to time dependently move at least one of the stimulus electrodes 3 for time-dependently changing the location of application of the electric stimulus to the intestinal mucosa for triggering release of GLP-1.
  • the entire stimulation system may be controlled by a control unit 4 (a microchip with a memory, a battery, and a data acquisition and elaboration software) which may be onboard the stimulus device 1 or remote from the stimulus device 1 and in signal communication (by conductive wire or wireless, e.g. by an RF transmitter-receiver communication channel) with the electrical pulse generator 2 and adapted to control the electrical pulse generator 2 in accordance with a preset stimulation program and or in dependency of signals received from an external controller or from food detection sensors 5, 6.
  • the control unit 4 may be adapted to elaborate the signals received from the food detection sensors (e.g. pressure sensors 5, electrical activity sensors 6, pH meter 7, glucose level sensor 8) to identify a condition of food intake and, in response to the identified condition of food intake, to generate a stimulus signal and provide the stimulus signal to the electrical pulse generator 2.
  • the food detection sensors e.g. pressure sensors 5, electrical activity sensors 6, pH meter 7, glucose level sensor 8
  • the food detection sensors may be linked by a signal communication line (by conductive wire or wireless, e.g. by an RF transmitter-receiver communication channel) to the control unit 4.
  • the stimulus electrodes 3 are linked to the electrical pulse generator 2 and adapted to apply an electrical stimulus to a tissue.
  • the stimulus electrodes 3 are movably supported on an electrode support 28 of the stimulus device 1 and an electrode moving device 29 is connected between the stimulus electrodes 3 and the electrode support 28 and adapted to move the stimulus electrodes 3 with respect to the electrode support 28.
  • the moving device 29 e.g.
  • a micromotor 45 with a rotating shaft 46 to which the stimulus electrodes 3 are attached for a rotational adjustment of their position, a micromotor 45 with jackscrew transmission 47 for a linear translational position adjustment, a thermally expandable and shrinkable element 48 with associated adjustable heat source 49, or a piezoelectric shape adjustable component 50, is linked to and controlled by the control unit 4 in dependency of a preset stimulus moving program and, if provided, of food detection signals or electrode movement signals received by the control unit 4.
  • the stimulus electrodes 3 of the electrical stimulus device 1 are arranged at a distance to one another in multiple positions and the stimulus device 1 is configured to time dependency switch selected ones of the stimulus electrodes 3 from an energized state to a non-energized state and vice versa for time-dependently changing the location of application of the stimulus.
  • the stimulus electrodes 3 are linked to the electrical pulse generator 2 and adapted to apply an electrical stimulus to a tissue.
  • the control unit 4 is adapted to control the pulse generator and to energize the individual pairs of stimulus electrodes 3 such that a stimulus current is multiplexed in an adjustable sequence to selected ones of the stimulus electrodes 3 in dependency of a preset stimulus moving program and, if provided, of food detection signals or stimulus position signals received by the control unit 4.
  • the alternation of the location of application of electric stimuli prevents the interested tissue from being "fried” or cauterized.
  • an electrode support 28 of the stimulus device 1 comprises one or more bioabsorbable or time-dependently dissolvable or fragmentable isolating layers or coatings 30 which cover a plurality of the stimulus electrodes 3, such that each one of the initially coated electrodes 3 becomes exposed only after a planned time (during which the one or more coatings or layers 30 overlaying that specific electrode 3 dissolve).
  • This allows to "replace" worn-out or dirty electrodes old with fresh unused electrodes to increase the lifetime of the stimulus electrode assembly and to alternate the location of exposed electrodes 3 over time.
  • this specific feature ( Figures 19, 20) of the invention can be implemented in combination with the previously described methods and devices for stimulating the release of GLP-1.
  • a method of stimulating the release of satiety hormone in a subject comprises extracorporeal ⁇ generating a plurality of electromagnetic fields in a plurality of positions at the body of the subject and overlapping the generated electromagnetic fields at a target location of a gastrointestinal system of the subject
  • the electromagnetic fields can be generated by means of a plurality of stimulus patches 31 ( Figure 21 ) having each an electromagnetic field generator 32 and an adhesive surface 33 for extracorporeal ⁇ fixating the stimulus patch 31 on the skin of the subject, as well as a control unit 4 linked to the field generators 32 of each stimulus patch 31 and operable to control the field generators 32 such that they generate electromagnetic fields overlapping in a target section of a gastrointestinal system of the subject.
  • the electromagnetic fields can be modulated and oriented such that only in the region of desired gut stimulation their vector sum provides sufficient energy to stimulate the release of GLP-1 , while in the remaining regions of the body subject to the electromagnetic fields, the vector sum of the field intensity remains low.
  • a marker 43 is provided which is implanted in the target section of the gastrointestinal system ( Figure 22) and which responds to or can be visualized by exposure to electromagnetic fields.
  • the positioning of the stimulus patches 31 and the generation of the electromagnetic fields are effected in dependency of the response by the marker 43 or in dependency of the visualized location of the marker 43.
  • the electromagnetic fields can be generated in a predetermined sequence which periodically stimulates one or more target zones of the gastrointestinal system, such that when nutrients are present in these target zones, the release of GLP-1 is triggered.
  • the electrical stimulus may be applied and varied at a frequency of about 0.1 Hz to about 90 Hz, at a voltage of about 0.5 V to about 25 V, with a pulse duration of about 0.1 ms to about 500 ms.
  • the electrical current may have a charge of about 1 ⁇ to about 6000 ⁇ , inclusive.
  • the electrical stimulus may be applied to a mucosal tissue of the gastrointestinal system of the subject, e.g in a duodenum, jejunum or ileum.
  • the present invention address the needs of reliable positioning of the stimulus device with respect to the desired location for stimulating the release of the satiety hormone GLP-1 , mini-invasively stimulating the gastrointestinal system and versatily adaption of the stimulation to the specific physiological situation and treatment plan. Moreover, a closed loop meal detection and intestinal electrical or electromagnetic stimulation is provided for a purposeful and timely release of the satiety hormone GLP-1 , resulting in an improved glycemic control and an appropriate feel of satiety in T2D and obese patients.

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Electrotherapy Devices (AREA)

Abstract

A system for stimulating the release of satiety hormone in a subject comprises a stimulus device (1) having an electrical pulse generator (2) and stimulus electrodes (3) adapted to apply an electrical stimulus to a tissue, the stimulus device (1) being configured to time dependently move at least one of the stimulus electrodes (3) for time-dependently changing the location of application of the stimulus.

Description

DESCRIPTION
"DEVICES AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS"
FIELD OF THE INVENTION
[0001] The present invention relates generally to devices and methods for the treatment of metabolic disorders using stimulation of the gastrointestinal tract. More specifically, the present invention relates to devices and methods for stimulating the intestine in order to trigger metabolic effects. The present invention further relates to a combined system for meal detection and stimulation of the small intestine (duodenum, jejunum or ileum) aiming at an increased secretion of endogenous GLP-1 during meal intake.
BACKGROUND OF THE INVENTION
[0002] The human ability to store excess energy has contributed to an increased frequency of morbidly obese patients and those with Type 2 Diabetes. Patients having such conditions have increased morbidity and mortality resulting from associated comorbidities, including cardiovascular disease and arthritis.
[0003] A sufficient release of Glucagon-Like Peptide (GLP-1), a known key hormone that regulates the body's glucose control hormone, is believed to alleviate Type 2 Diabetes and obesity. Normally, the presence of nutrients, which arise from a meal consisting of carbohydrates, fats and proteins, termed 'digesta' in the digestive tract, stimulates release of the body's own GLP-1 key hormone into the blood stream. Key hormones, released by specialized L-cells located in the mucosa, which is the innermost interior (luminal) wall of the intestines, coordinate the body's response to a meal. The hormones produce this effect by inducing a sense of fullness and cessation of eating (satiety), triggering the release of insulin to maintain proper glucose levels (incretin effect) and slowing the passage of contents through the digestive tract (delaying gastric emptying and slowing small intestinal transit). Altogether, these effects have been referred to as the "ileal brake" mechanism which involves both the hormones that play a role (such as PYY, GLP-1 , and GLP-2, among others), as well as the multiplicity of effects of release of those hormones (gastric emptying, a feeling of fullness cessation of eating, triggering of insulin secretion).
[0004] An insufficient ileal brake, i .e. , the inability of the body to release sufficient quantities of these hormones in response to a meal, is a contributory factor in obesity and Type 2 Diabetes. While in non-obese non-diabetic individuals fasting levels of GLP-1 are observed to be in the range of 5-10 pmol/L and to increase rapidly to 15-50 pmol/L after a meal, in T2D patients, the meal-related increase in GLP-1 is significantly less. The decreased insulin levels of such patients are attributable to an insufficient level of GLP-1. Similarly, also in obese subjects lower basal fasting hormone levels and smaller meal- associated rise of the hormone levels have been observed. Therefore, enhancing the body's endogenous levels of GLP-1 is believed to have impact on both obesity and diabetes.
[0005] There are known pharmaceutical means to increasing the endogenous active forms of GLP-1 , e. g. by inhibition of its breakdown by dipeptidyl peptidase-4 (DPP-4) inhibitors, such as vildagliptin. In diabetic patients, improvement in glucose control is obtained by increasing the circulating levels of GLP-1 by vildagliptin.
[0006] As an alternative to pharmacological treatments, the most effective treatment for morbid obesity is bariatric surgery. A number of studies in patients after bariatric surgery suggest that there are increases in meal-related circulating GLP-1 levels after surgery, which contribute to the improvements in T2D and weight loss noted. However, bariatric surgery is perceived as a highly invasive measure recommended only for morbidly obese patients. A less invasive approach using a duodenal impermeable sleeve placed via an endoscope and fastened e.g. with a barbed metal anchor at the duodenal entrance has also shown to improve the glucose control.
[0007] It has been hypothesized that the manipulation of the intestine during and after surgery resulted in a stimulation of the mucosa which resulted in an increased release of the satiety hormone(s). US2010/0056948 describes a method of stimulating the release of satiety hormones in a subject comprising applying an electrical stimulus to a tissue in the gastrointestinal system of the subject contemporaneously with the contacting of L-cells of the tissue with a nutrient stimulus.
[0008] However, there remains sti ll a need of improved methods and devices for stimulating the gastrointestinal system which better address the patients' fear of surgery, which are less invasive and which assure an improved patient comfort during treatment. Moreover, there is a need of improved methods and devices for accessing the stimulation site in the Gl system, as well as for positioning and anchoring stimulus equipment on the patient. Further there is a need of improved methods and devices for an easier adaption of the stimulation to the specific metabolic disease and organic situation of a patient, as well as to any desired therapeutic treatment plan.
SUMMARY OF THE INVENTION
[0009] In accordance with an aspect of the invention, a method is provided of stimulating the release of satiety hormone in a subject, the method comprising applying one of an electrical and electromagnetic stimulus to a tissue of a gastrointestinal system of the subject and time dependency changing the location of application of the stimulus at the tissue.
[0010] In accordance with an aspect of the invention, a system for stimulating the release of satiety hormone in a subject comprises a stimulus device having an electrical pulse generator and stimulus electrodes adapted to apply an electrical stimulus to a tissue, the stimulus device being configured to time dependency move at least one of the stimulus electrodes for time-dependently changing the location of application of the stimulus.
[0011] In an aspect of the invention there is provided a method of stimulating the release of satiety hormone in a subject, the method comprising providing an electrical stimulus device having an electrical pulse generator and electrical stimulus electrodes, transporting the electrical stimulus device endoluminally to a target location in a gastrointestinal system of the subject, anchoring the stimulus device in the target location such that the stimulus electrodes engage a tissue of the gastrointestinal system, and applying an electrical stimulus to the tissue by means of the stimulus device.
[0012] In a further aspect of the invention, a system is provided for stimulating the release of satiety hormone in a subject, the system comprising a stimulus device having an electrical pulse generator and stimulus electrodes adapted to apply an electrical stimulus to a tissue, the stimulus device being adapted to be endoluminally introduced in a gastrointestinal system of the subject, the system further comprising means for permanently anchoring the stimulus device in a target location inside the gastrointestinal system i n a positi on i n which the sti m u l us el ectrodes engage a tissue of the gastrointestinal system at the target location.
[0013] In accordance with a further aspect, a method of stimulating the release of satiety hormone in a subject comprises providing an electrical stimulus device having an electrical pulse generator and electrical stimulus electrodes, placing the stimulus device in an abdominal space of the subject at the outside of a target lumen of intestine, anchoring the stimulus device at the target lumen such that the stimulus electrodes engage a tissue of the target lumen from outside the target lumen, and applying an electrical stimulus to the tissue by means of the stimulus device.
[0014] In accordance with an aspect of the invention, a system for stimulating the release of satiety hormone in a subject comprises a stimulus band configured to be deformable from an open shape to a closed ring shape and lockable in the closed ring shape, multiple stimulation electrodes arranged at the stimulus band such that they can contact a section of small intestine when the stimulus band is placed from outside around said section of small intestine, an electrical pulse generator arranged at the stimulus band and operable to energize the stimulus electrodes.
[0015] In accordance with a yet further aspect, the method comprises continuously monitoring at least one characteristic of the subject to detect an ingestion of food by the subject, and applying the electrical or electromagnetic stimulus to the gastrointestinal system in response to a detected ingestion of food. For this purpose, the proposed system comprises a detection device which is implantable in the subject and adapted to continuously monitoring at least one of a mechanical characteristic and an electrical characteristic of the subject to detect an ingestion of food by the subject, and the detection device cooperates with the stimulus device such that the stimulus device applies the electrical stimulus in response to a detected ingestion of food.
[0016] These and other aspects and advantages of the present invention shall be made apparent from the accompanying drawings and the description thereof, which illustrate embodiments of the invention and, together with the general description of the invention given above, and the detailed description of the embodiments given below, serve to explain the principles of the present invention.
BRIEF DESCRIPTION OF THE DRAWINGS
- Figure 1 shows a schematic block diagram of a meal detection and electrical stimulation system for stimulating the release of satiety hormones in accordance with an embodiment; - Figure 2 illustrates a first embodiment of an electrical stimulation system for stimulating the release of satiety hormones, the system being endoluminally implanted in a Gl tract;
- Figure 3 illustrates a second embodiment of an electrical stimulation system for stimulating the release of satiety hormones, the system being endoluminally implanted in a Gl tract;
- Figure 4 illustrates a third embodiment of an electrical stimulation system for stimulating the release of satiety hormones, the system being endoluminally implanted in a Gl tract;
- Figures 5 through 10 illustrate further embodiments of an electrical stimulation system for stimulating the release of satiety hormones, the systems being endoluminally implanted in a Gl tract;
- Figure 1 1 illustrates an embodiment of an electrical stimulation system for stimulating the release of satiety hormones, the system having a stimulus band laparoscopically inserted in an abdominal space placed around a lumen of a Gl tract;
- Figure 12 shows the stimulus band of figure 1 1 in a frontal view and in a longitudinal section; - Figure 13 illustrates a further embodiment of an electrical stimulation system for stimulating the release of satiety hormones, the system being endoluminally placed in a section of the ileum and in a section of colon of a patient;
- Figures 14 and 15 illustrate electrical stimulation systems in accordance with further exemplary embodiments;
- Figures 16 and 17 are schematic illustrations of an electrical stimulation system for stimulating the release of satiety hormones in accordance with embodiments, in which the location of stimulation can be varied over time;
- Figure 18 illustrates a further embodiment of an electrical stimulation system for stimulating the release of satiety hormones;
- Figure 19 illustrates a yet further embodiment of an electrical stimulation system for stimulating the release of satiety hormones;
- Figure 20 illustrates a detail of an electrical stimulation device for stimulating the release of satiety hormones, in accordance with an embodiment;
- Figure 21 illustrates an adhesive patch electromagnetic stimulation device in accordance with an embodiment;
- Figure 22 shows a method of stimulating the release of satiety hormones involving an extracorporeal application of adhesive patch stimulating devices of figure 21 ;
- Figure 23 shows a method for stimulating the release of satiety hormones involving stimulation devices of the invention;
- Figure 24 shows a method and devices for stimulating the release of satiety hormones in accordance with a further embodiment;
- Figure 25, 26 and 27 illustrate a swallowable electrical stimulating pill in accordance with embodiments of the invention;
- Figure 25A illustrates an extracorporeal adhesive magnetic patch for holding the swallowable pill of figure 25 in a planned position in a Gl tract;
- Figures 28A, 28B, 28C, 28D illustrate electrode movement devices in accordance with embodiments of the invention.
DETAILED DESCRIPTION OF EMBODIMENTS
[0017] Referring to the drawings in which like numerals denote like anatomical structures and components throughout the several views, methods and devices are provided for stimulating the release of satiety hormone, specifically GLP-1 , in a human subject.
DETAILED DESCRIPTION OF EMBODIMENTS OF FIGURES 1-10, 13,23-27
[0018] In accordance with a first aspect of the invention (Figures 1 - 10, 13), a method of stimulating the release of satiety hormone in a subject comprises:
- providing an electrical stimulus device 1 having an electrical pulse generator 2 and electrical stimulus electrodes 3,
- transporting the electrical stimulus device 1 endoluminally to a target location in a gastrointestinal system of the subject,
- anchoring the stimulus device 1 in the target location such that the stimulus electrodes 3 engage a tissue of the gastrointestinal system, and
- applying an electrical stimulus to the tissue by means of the stimulus device 1.
[0019] As schematically shown in figure 1 , the entire stimulation system may be controlled by a control unit 4 (a microchip with a memory, a battery, and a data acquisition and elaboration software) which may be onboard the stimulus device 1 or remote from the stimulus device 1 and in signal communication (by conductive wire or wireless, e.g. by an RF transmitter-receiver communication channel) with the electrical pulse generator 2 and adapted to control the electrical pulse generator 2 in accordance with a preset stimulation program and or in dependency of signals received from an external controller 44 (Figure 23) or from food detection sensors 5, 6. For this purpose the control unit 4 may be adapted to elaborate the signals received from the food detection sensors (e.g. pressure sensors 5, electrical activity sensors 6, pH meter 7, glucose level sensor 8) to identify a condition of food intake and, in response to the identified condition of food intake, to generate a stimulus signal and provide the stimulus signal to the electrical pulse generator 2.
[0020] If provided , also the food detection sensors may be linked by a signal communication line (by conductive wire or wireless, e.g. by an RF transmitter-receiver communication channel) to the control unit 4.
[0021] The stimulus electrodes 3 are linked to the electrical pulse generator 2 and adapted to apply an electrical stimulus to a tissue. The stimulus device 1 itself is adapted to be endoluminally introduced (e.g. transorally or transanally) in the gastrointestinal system of the patient, and means are provided for permanently anchoring the stimulus device 1 in a target location inside the gastrointestinal system.
[0022] In accordance with an embodiment (Figure 2) the anchoring means may comprise an expandable balloon shaped or coil shaped anchoring body 9 which is endoluminally inserted inside a stomach 10 of the patient and then expanded to hold itself inside the stomach 10. Food detecting sensors, such as a pressure sensor 5 and/or a pH meter 7 and/or a pair of detecting electrodes 6 may be arranged on the anchoring body 9 so that after placement of the anchoring body 9, at least one of a pressure, pH and electrical current in the gastric wall can be monitored by the food detecting sensors and transmitted to the control unit 4. The control unit 4 and the pulse generator 2 are also received in the anchoring body 9 and one or more pairs of stimulus electrodes 3 are provided at a distance from the anchoring body 9 and connected by electrical wires 1 1 to the pulse generator 2, so that the wires 1 1 can extend from the anchoring body 9 which is placed inside the stomach 10 through the pylorus 12 down into the small intestine (ad es. duodenum 13) where the stimulus electrodes 3 engage and electrically stimulate an intestinal mucosa to produce endogenous GLP-1. In this embodiment, the electrical wires 1 1 (which can be united in one single wire bundle) accomplish both electrical energizing and pull resistant mechanical connection of the electrodes 3 to the anchoring body 9.
[0023] I n accordance with exemplary embodiments, the stimulus electrodes 3 may comprise plate like electrode pads (Figure 8) with or without an adhesive layer for a reliable attachment to the intestinal mucosa, coiled electrode arrangements (Figures 5, 7) or metal mesh stent arrangements (Figure 6) adapted to be expanded from an initially compacted shape to a radially expanded shape for engaging the intestinal wall by contact pressure, or corkscrew shaped electrode arrangements adapted to be screwed into an intestinal mucosa (Figure 9). The stimulus electrodes 3 may be elastically held in contact with the tissue by means of an elastic spring attached thereto, e.g. a Nitinol spring, or a flexible elastomeric sponge (Figure 18) which can also elastically follow peristalsis movements of the intestine.
[0024] I n accordance with a further embodiment, the electrical pulse generator 2 is connected to an RF transmitter circuit and antennae 14 for a wireless transmission of the electrical stimulation energy and signals, and the electrode 3 arrangement comprises an RF receiving circuit and antenna 15 for a wireless reception of the stimulation energy and signals (a wireless transmission of the stimulating energy can be obviated by providing the stimulus electrode arrangement 3 with an onboard power source or battery). In this embodiment, the wires 1 1 are not necessary, however, the electrode 3 arrangement must be directly anchored inside the small intestine (Figure 6) or connected to the anchoring body 9 by means of a tether 18 (Figure 6).
[0025] I n accordance with a further embodiment (Figure 3), the anchoring means comprise a proximal annular flange 16 (forming the above said anchoring body 9) which may be rigid or expandable from an initially collapsed shape which allows endoluminal insertion thereof into the stomach 10 to an expanded shape which allows the proximal flange 16 to be seated in the antrum of the stomach without migrating distally through the pylorus. The anchoring means further comprise a distal annular flange 17 which may be rigid or expandable from an initially collapsed shape which allows endoluminal insertion thereof into the duodenum 13 to an expanded shape which allows the distal flange 17 to be seated in the proximal duodenum without migrating proximally through the pylorus back into the stomach. The proximal and distal flanges 16, 17 are connected to each other by a pull resistant tether 18 adapted to flexibly extend through the pylorus, such that the flanges 16, 17 hold the pylorus between them.
[0026] Also in this embodiment, food detecting sensors, such as a pressure sensor 5 and/or a pH meter 7 and/or a pair of detecting electrodes 6, the control unit 4 and the pulse generator 2 may be arranged in the proximal flange 16 and one or more pairs of stimulus electrodes 3 are provided at or connected to the distal flange 17 in intimate contact with the intestinal wall for electrically stimulating the mucosa to produce endogenous GLP-1. The stimulus electrodes 3 may be connected by electrical wires to the pulse generator 2 at the proximal flange 16, so that the electrical wires (which can be united in one single wire bundle) accomplish both electrical connection and pull resistant mechanical tethering between the two flanges 16, 17.
[0027] Also in this embodiment, the stimulus electrodes 3 may comprise plate like electrode pads (Figure 8) with or without an adhesive layer for a reliable attachment to the intestinal mucosa, coiled electrode arrangements (Figures 5, 7) or metal mesh stent arrangements (Figure 6) adapted to be expanded from an initially compacted shape to a radially expanded shape for engaging the intestinal wall by contact pressure, or corkscrew shaped electrode arrangements adapted to be screwed into an intestinal mucosa (Figure 9). The stimulus electrodes 3 may be elastically held in contact with the tissue by means of an elastic spring attached thereto, e.g. a Nitinol spring, or a flexible elastomeric sponge (Figure 18) which can also elastically follow peristalsis movements of the intestine.
[0028] I n accordance with a further embodiment, the electrical pulse generator 2 is connected to an RF transmitter circuit and antennae 14 at the proximal flange 16 for a wireless transmission of the electrical stimulation energy and signals, and the electrode 3 arrangement comprises an RF receiving circuit and antenna 15 (preferably at the distal flange 17) for a wireless reception of the stimulation energy and signals.
[0029] In accordance with a yet further embodiment (Figures 13, 14, 15) the anchoring means comprise an expandable colonic stent 20 which is endoluminally placed and expanded within a colon 19 of the patient. The control unit 4 and the pulse generator 2 may be connected to or received inside the colonic stent 20 and one or more pairs of stimulus electrodes 3 are arranged at a distance from the colonic stent 20 and adapted to intimately engage an ileal mucosa from inside an ileum 21 of the patient for electrically stimulating the ileal mucosa to produce endogenous GLP-1. The stimulus electrodes 3 may be connected by electrical wires to the pulse generator 2 at the colonic stent 20 (Figure 15). Alternatively (Figures 13, 14), the electrical pulse generator 2 is connected to an RF transm itter circuit and antennae 14 at the colonic stent 20 for a wi reless transmission of the electrical stimulation energy and signals, and the electrode 3 arrangement comprises an RF receiving circuit and antenna 15 for a wireless reception of the stimulation energy and signals (a wireless transmission of the stimulating energy can be obviated by providing the stimulus electrode arrangement 3 with an onboard power source or battery). The control unit 4 can be further connected to a RF receiver for a wireless reception of food detection signals.
[0030] Also in this embodiment, the stimulus electrodes 3 may comprise plate like electrode pads with or without an adhesive layer for a reliable attachment to the intestinal mucosa, coiled electrode arrangements (Figures 13, 14, 1 5) or metal mesh stent arrangements adapted to be expanded from an initially compacted shape to a radially expanded shape for engaging the intestinal wall by contact pressure, or corkscrew shaped electrode arrangements adapted to be screwed into an intestinal mucosa. The stimulus electrodes 3 may be elastically held in contact with the tissue by means of an elastic spring attached thereto, e.g. a Nitinol spring, or a flexible elastomeric sponge (Figure 18) which can also elastically follow peristalsis movements of the intestine.
[0031] I n accordance with a yet further embodiment, the stimulus electrodes 3 may comprise a metal mesh stent arrangement adapted to be expanded from an initially compacted shape to a radially expanded shape for engaging the intestinal wall by contact pressure, wherein however the electrical pulse generator 2 is directly arranged onboard the electrode stent (Figure 7) and not carried by the anchoring means as in the previously described embodiments.
[0032] In general, a metal mesh stent stimulus electrode 3 arrangement contemplated by the invention may comprise two non-isolated electrically conductive paths 22, 23 that are arranged to one another in an overlapping manner and that are expandable from a first collapsed shape (adapted for endoscopic insertion) to a second expanded shape (adapted to engage the intestinal mucosa), both paths 22, 23 being isolated from each other at each overlapping point, e.g. by means of an isolating component 24 defining a hinge between both conductive paths 22, 23 (Figure 7).
[0033] In accordance with a yet further embodiment (Figure 10), the stimulus electrodes 3 may be arranged on an external surface of an endoluminal, e.g. duodenal, flexible sleeve 25 which is connected to the anchoring means (expandable gastric anchoring body 9, balloon, coil, flanges 16, 17) by a tether 18 or by electrical wire 1 1 acting both as electrical conductor and as tether.
[0034] In a yet further embodiment (Figure 24), the stimulus electrodes 3 may be arranged on an external surface of an endoluminal bile diverting sleeve 25' which has a proximal end portion 35 inserted inside the biliary tree 34 and a distal portion 36 extended inside the duodenum 13. The sleeve 25' may be anchored against undesired distal migration in the biliary tree or in the duodenum or in the stomach. The stimulus electrodes 3 may be arranged in discrete positions or continuous conductive paths anywhere on the sleeve 25'.
[0035] In accordance with a yet further embodiment (Figures 25 to 27) the electrical stimulus device 1 may comprise an orally swallowable pill 37 which is orally administered to the patient and adapted to travel endoluminally to a target section of the gastrointestinal system. Food detecting sensors, such as a pressure sensor 5 and/or a pH meter 7 and/or a pair of detecting electrodes 6 may be arranged on the pill 37 so that, after placement of the pill 37, at least one of a pressure, pH or electrical current in the intestinal wall can be monitored by the food detecting sensors and transmitted to the control unit 4. The control unit 4 and the pulse generator 2 are also received in the pill 37 and one or more pairs of stimulus electrodes 3 are supported by the pill 37 and electrically connected to the pulse generator 2 such that they can engage and electrically stimulate an intestinal mucosa to produce endogenous GLP-1.
[0036] In order to hold the stimulus pill 37 in the desired position within the Gl tract, the system may further comprise magnetic anchoring means, such as an extracorporeal belt or adhesive patch 42 (Figure 25A) which can be fastened to the patient or an anchoring band adapted to be applied from outside around the target section of intestinal lumen. These anchoring means have a permanent magnetic or electromagnetic field source 38 adapted to cooperate with an onboard magnet 39 housed in the swallowable pill 37 to block the swallowable pill 37 in place, e.g. in the duodenum 13 or ileum 21. Alternative or additional mechanical anchoring means may include a temperature sensitive shape memory anchor 40 connected to the pill 37 and adapted to deform from a collapsed shape (broken line in Figures 26, 27, adapted for endoluminal transit) to an expanded shape (solid line in Figures 26, 27, adapted for anchoring). In order to trigger the transition of the anchor 40 from the collapsed shape to the expanded shape, the pill may comprise a heater, e.g. an electric resistance 41 , arranged in heat exchanging relationship with the shape memory anchor 40 and energized by the control unit 4. In accordance with non- limiting, exemplary embodiments, the shape memory anchor 40 may have:
- a coiled or spirally coiled shape and extend initially around the pill 37 (Figure 26, 27) and, after expansion, the anchor 40 may form a coiled tail (Figure 27) extending axially and radially away from the pill, or
- a coiled or spirally coiled shape and extend initially around the pill 37 (Figure 26, 27) and, after expansion, the anchor 40 may form a coiled envelop (Figure 26) extending only radially away from the pill. I n both embodiments, the stimulus electrodes 3 may be supported by the shape memory anchor 40 to intimately engage the intestinal mucosa.
DETAILED DESCRIPTION OF EMBODIMENTS OF FIGURES 1. 1 1. 12
[0037] In accordance with a further aspect of the invention, a method of stimulating the release of satiety hormone in a subject comprises:
- providing an electrical stimulus device 1 having an electrical pulse generator 2 and electrical stimulus electrodes 3,
- placing the stimulus device 1 in an abdominal space of the subject at the outside of a target lumen of intestine,
- anchoring the stimulus device 1 at the target lumen such that the stimulus electrodes 3 engage a tissue of the target lumen from outside the target lumen, and
- applying an electrical stimulus to the tissue by means of the stimulus device 1.
[0038] In accordance with an embodiment, the stimulus device 1 may comprise a stimulus band 26 configured to be deformable from an open shape to a closed ring shape and lockable in the closed ring shape, multiple stimulation electrodes 3 arranged at the stimulus band 26 such that they can contact a section of small intestine when the stimulus band 26 is placed from outside around the section of small intestine, and an electrical pulse generator 2 arranged at the stimulus band 26 and operable to energize the stimulus electrodes 3.
[0039] The stimulus electrodes 3 may be provided on a radially internal surface of the stimulus band 26 to engage the intestine, e.g. the duodenum 13 from outside. Moreover a ridge 27 can be formed on the internal surface of the stimulus band 26 in a direction that the ridge 27 circumferentially engages the intestinal lumen around which the stimulus band 26 is fastened and prevents undesired displacement of the stimulus band 26 along the lumen. [0040] Placement of the stimulus band 26 may be effected by open surgery or by laparoscopy, but also by endolumenal transportation of the band 26 to the desired site for stimulating the production of GLP-1 , translumenal placement of the band 26 from inside the intestine through an incision in the lumen wall to its outside and extension of the band from outside the lumen around the lumen.
[0041] After placement of the stimulus band 26 around the intestine, the pulse generator 2 can be activated to apply the electrical stimulus from the outside to the tissue.
[0042] The general operational scheme previously described and illustrated in figure 1 applies analogously. For instance, both the control unit 4 and the pulse generator 2 may be connected to or received inside the stimulus band 26 and the stimulus electrodes 3 may be connected by electrical wires to the pulse generator 2. Alternatively, the control unit 4 and/or the electrical pulse generator 2 (onboard the stimulus band 26 or remote from the stimulus band 2 is connected to an RF transmitter circuit and antennae for a wireless transmission of the electrical stimulation energy and/or signals, and the stimulus electrodes 3 at the band 26 are linked to an RF receiving circuit and antenna for a wireless reception of the stimulation energy and/or signals (a wireless transmission of the stimulating energy can be obviated by providing an onboard power source or battery in the stimulus band 26). The control unit 4 can be further connected to a RF receiver for a wireless reception of food detection signals.
DETAILED DESCRIPTION OF EMBODIMENTS OF FIGURES 1 ,16,17, 19,20
[0043] In accordance with a further aspect, a method is provided of stimulating the release of satiety hormone in a patient, the method comprising applying one of an electrical and electromagnetic stimulus to a tissue of a gastrointestinal system of the subject and time dependently changing the location of application of the stimulus at the tissue. A time- dependent change or variation of the location of application of the electrical stimulus may be desirable to optimize the treatment or maximize the release of GLP-1 , as well as to reducing a risk of tissue trauma (by burning) due to a continued electric stimulus.
[0044] In accordance with an embodiment (Figure 16), the method can be implemented by means of a stimulus device 1 which is configured to time dependently move at least one of the stimulus electrodes 3 for time-dependently changing the location of application of the electric stimulus to the intestinal mucosa for triggering release of GLP-1.
[0045] As schematically shown in figure 1 , the entire stimulation system may be controlled by a control unit 4 (a microchip with a memory, a battery, and a data acquisition and elaboration software) which may be onboard the stimulus device 1 or remote from the stimulus device 1 and in signal communication (by conductive wire or wireless, e.g. by an RF transmitter-receiver communication channel) with the electrical pulse generator 2 and adapted to control the electrical pulse generator 2 in accordance with a preset stimulation program and or in dependency of signals received from an external controller or from food detection sensors 5, 6. For this purpose the control unit 4 may be adapted to elaborate the signals received from the food detection sensors (e.g. pressure sensors 5, electrical activity sensors 6, pH meter 7, glucose level sensor 8) to identify a condition of food intake and, in response to the identified condition of food intake, to generate a stimulus signal and provide the stimulus signal to the electrical pulse generator 2.
[0046] If provided, also the food detection sensors may be linked by a signal communication line (by conductive wire or wireless, e.g. by an RF transmitter-receiver communication channel) to the control unit 4.
[0047] The stimulus electrodes 3 are linked to the electrical pulse generator 2 and adapted to apply an electrical stimulus to a tissue. The stimulus electrodes 3 are movably supported on an electrode support 28 of the stimulus device 1 and an electrode moving device 29 is connected between the stimulus electrodes 3 and the electrode support 28 and adapted to move the stimulus electrodes 3 with respect to the electrode support 28. The moving device 29, e.g. a micromotor 45 with a rotating shaft 46 to which the stimulus electrodes 3 are attached for a rotational adjustment of their position, a micromotor 45 with jackscrew transmission 47 for a linear translational position adjustment, a thermally expandable and shrinkable element 48 with associated adjustable heat source 49, or a piezoelectric shape adjustable component 50, is linked to and controlled by the control unit 4 in dependency of a preset stimulus moving program and, if provided, of food detection signals or electrode movement signals received by the control unit 4.
[0048] The skilled person will appreciate that the described features (Figure 16) of the invention can be implemented in combination with the previously described methods and devices for stimulating the release of GLP-1.
[0049] In accordance with a further embodiment (Figure 17), the stimulus electrodes 3 of the electrical stimulus device 1 are arranged at a distance to one another in multiple positions and the stimulus device 1 is configured to time dependency switch selected ones of the stimulus electrodes 3 from an energized state to a non-energized state and vice versa for time-dependently changing the location of application of the stimulus.
[0050] The stimulus electrodes 3 are linked to the electrical pulse generator 2 and adapted to apply an electrical stimulus to a tissue. The control unit 4 is adapted to control the pulse generator and to energize the individual pairs of stimulus electrodes 3 such that a stimulus current is multiplexed in an adjustable sequence to selected ones of the stimulus electrodes 3 in dependency of a preset stimulus moving program and, if provided, of food detection signals or stimulus position signals received by the control unit 4. The alternation of the location of application of electric stimuli prevents the interested tissue from being "fried" or cauterized. The skilled person will appreciate that this specific feature (Figure 17) of the invention can be implemented in combination with the previously described methods and devices for stimulating the release of GLP-1.
[0051] In accordance with a yet further embodiment (Figures 19, 20) an electrode support 28 of the stimulus device 1 comprises one or more bioabsorbable or time-dependently dissolvable or fragmentable isolating layers or coatings 30 which cover a plurality of the stimulus electrodes 3, such that each one of the initially coated electrodes 3 becomes exposed only after a planned time (during which the one or more coatings or layers 30 overlaying that specific electrode 3 dissolve). This allows to "replace" worn-out or dirty electrodes old with fresh unused electrodes to increase the lifetime of the stimulus electrode assembly and to alternate the location of exposed electrodes 3 over time. The skilled person will appreciate that this specific feature (Figures 19, 20) of the invention can be implemented in combination with the previously described methods and devices for stimulating the release of GLP-1.
DETAILED DESCRIPTION OF EMBODIMENTS OF FIGURES 1 , 21 , 22
[0052] In accordance with an aspect of the invention, a method of stimulating the release of satiety hormone in a subject comprises extracorporeal^ generating a plurality of electromagnetic fields in a plurality of positions at the body of the subject and overlapping the generated electromagnetic fields at a target location of a gastrointestinal system of the subject
[0053] The electromagnetic fields can be generated by means of a plurality of stimulus patches 31 (Figure 21 ) having each an electromagnetic field generator 32 and an adhesive surface 33 for extracorporeal^ fixating the stimulus patch 31 on the skin of the subject, as well as a control unit 4 linked to the field generators 32 of each stimulus patch 31 and operable to control the field generators 32 such that they generate electromagnetic fields overlapping in a target section of a gastrointestinal system of the subject. The electromagnetic fields can be modulated and oriented such that only in the region of desired gut stimulation their vector sum provides sufficient energy to stimulate the release of GLP-1 , while in the remaining regions of the body subject to the electromagnetic fields, the vector sum of the field intensity remains low.
[0054] In accordance with an embodiment, a marker 43 is provided which is implanted in the target section of the gastrointestinal system (Figure 22) and which responds to or can be visualized by exposure to electromagnetic fields. The positioning of the stimulus patches 31 and the generation of the electromagnetic fields are effected in dependency of the response by the marker 43 or in dependency of the visualized location of the marker 43.
[0055] In accordance with a yet further embodiment, the electromagnetic fields can be generated in a predetermined sequence which periodically stimulates one or more target zones of the gastrointestinal system, such that when nutrients are present in these target zones, the release of GLP-1 is triggered.
[0056] In exemplary embodiments, the electrical stimulus may be applied and varied at a frequency of about 0.1 Hz to about 90 Hz, at a voltage of about 0.5 V to about 25 V, with a pulse duration of about 0.1 ms to about 500 ms. The electrical current may have a charge of about 1 μθ to about 6000 μθ, inclusive. The electrical stimulus may be applied to a mucosal tissue of the gastrointestinal system of the subject, e.g in a duodenum, jejunum or ileum.
[0057] The present invention address the needs of reliable positioning of the stimulus device with respect to the desired location for stimulating the release of the satiety hormone GLP-1 , mini-invasively stimulating the gastrointestinal system and versatily adaption of the stimulation to the specific physiological situation and treatment plan. Moreover, a closed loop meal detection and intestinal electrical or electromagnetic stimulation is provided for a purposeful and timely release of the satiety hormone GLP-1 , resulting in an improved glycemic control and an appropriate feel of satiety in T2D and obese patients.
[0058] Although preferred embodiments of the invention have been described in detail, it is not the intention of the applicant to limit the scope of the claims to such particular embodiments, but to cover all modifications and alternative constructions falling within the scope of the invention.

Claims

Claims
1. A system for stimulating the release of satiety hormone in a subject, the system comprising a stimulus device (1) having an electrical pulse generator (2) and stimulus electrodes (3) adapted to apply an electrical stimulus to a tissue, said stimulus device (1) being configured to time dependency move at least one of the stimulus electrodes (3) for time-dependently changing the location of application of the stimulus.
2. A system according to claim 1 , in which the stimulus electrodes (3) are movably supported on an electrode support (28) of the stimulus device (1) and an electrode moving device (29) is arranged on the electrode support (28) and adapted to move the stimulus electrodes (3) with respect to the electrode support (28), said moving device (29) being operable by a control unit (4) of the system in dependency of a preset stimulus moving program and, if provided, of food detection signals or electrode movement signals received by the control unit (4).
3. A system according to claim 1 or 2, in which said moving device (29) is selected in the group consisting of:
- a micromotor (45) with a rotating shaft (46) to which the stimulus electrodes (3) are attached for a rotational adjustment of their position,
- a micromotor (45) with jackscrew transmission (47) for a linear translational position adjustment of the stimulus electrodes (3),
- a thermally expandable and shrinkable element (48) with associated adjustable heat source (49),
- a piezoelectric shape adjustable component (50).
4. A system according to any one of the preceding claims, wherein said stimulus device (1) is adapted to be endoluminally introduced in a gastrointestinal system of the subject, said system further comprising means (9, 16, 17, 42) for anchoring the stimulus device (1) in a target location inside the gastrointestinal system in a position in which the stimulus electrodes (3) engage a tissue of said gastrointestinal system.
5. System according to claim 4, in which the anchoring means comprise an expandable balloon or coil shaped anchoring body (9) which is endoluminally insertable inside a stomach (10) of the subject and expandable to hold itself inside the stomach (10).
6. System according to claim 5, wherein the pulse generator (2) is housed in the anchoring body (9) and the stimulus electrodes (3) are provided at a distance from the anchoring body (9) and in signal communication with the pulse generator (2).
7. System according to claim 5 or 6, comprising at least one food detecting sensor (5, 6, 7) arranged on the anchoring body (9) and adapted to detect a presence of food in the stomach (10).
8. System according to claim 4, in which the anchoring means comprise:
- an a proximal annular flange (16) adapted to be endoluminally seated in an antrum of a stomach without migrating distally through the pylorus, and
- a distal annular flange (17) adapted to be endoluminally seated in a proximal duodenum without migrating proximally through the pylorus back into the stomach,
the proximal and distal flanges (16, 17) being connected to each other by a tether (18) such that the flanges (16, 17) can hold the pylorus between them.
9. System according to claim 8, comprising at least one food detecting sensor (5, 6, 7) arranged on the proximal flange (16) and adapted to detect a presence of food in the stomach (10).
10. System according to claim 8 or 9, in which the pulse generator (2) is arranged in the proximal flange (16) and said stimulus electrodes (3) are provided at the distal flange (17) and in signal communication with said pulse generator (2).
11. System according to claim 4, in which the anchoring means comprise an expandable colonic stent (20) adapted to be endoluminally placed and expanded within a colon (19) of the subject, said pulse generator (2) being attached to the colonic stent (20) and said stimulus electrodes (3) being arranged at a distance from the colonic stent (20) and in signal communication with the pulse generator (2).
12. System according to any one of the preceding claims, wherein the electrical pulse generator (2) is connected to an RF transmitter circuit and antennae (14) for a wireless transmission of the electrical stimulation energy and signals, and the stimulus electrodes (3) are connected to an RF receiving circuit and antenna (15) for a wireless reception of the stimulation energy and signals.
13. System according to claim 1 , wherein said stimulus electrodes (3) comprise at least two pairs of stimulus electrodes arranged at a distance to one another in multiple positions and the stimulus device (1) is configured to time dependency switch selected ones of the stimulus electrodes from an energized state to a non-energized state and vice versa for time-dependently changing the location of application of the stimulus while maintaining a set stimulus electrode position.
14. System according to any one of the preceding claims, comprising one or more time- dependently bioabsorbable or biofragmentable isolating layers (30) which cover at least one of the stimulus electrodes (3), said initially covered stimulus electrode (3) being exposed only after erosion of said one or more isolating layers (30).
15. System according to claim 1 , comprising an orally swallowable pill (37) adapted to travel endoluminally to a target section of a gastrointestinal system, said swallowable pill (37) housing said stimulus device (1).
16. System according to claim 1 , comprising a stimulus band (26) configured to be deformable from an open shape to a closed ring shape and lockable in the closed ring shape,
said stimulus band (26) housing said stimulus device (1) such that the stimulus electrodes (3) can contact a section of small intestine when the stimulus band (26) is placed from outside around the section of small intestine.
17. System according to claim 1 , in which the stimulus electrodes (3) are arranged on an external surface of a flexible endoluminal sleeve (25).
18. System according to claim 1 , in which the stimulus electrodes (3) are arranged on an external surface of an endoluminal bile diverting sleeve (25') which has a proximal end portion (35) adapted to be placed inside a biliary tree (34) and a distal portion (36) adapted to be extended inside a duodenum (13).
19. A method of stimulating the release of satiety hormone in a subject comprising:
- applyi ng one of an electrical and electromag netic sti m u l us to a tissue of a gastrointestinal system of the subject;
- time dependency changing the location of application of the stimulus at said tissue.
PCT/EP2012/055795 2012-03-30 2012-03-30 Devices and methods for the treatment of metabolic disorders. WO2013143599A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/055795 WO2013143599A1 (en) 2012-03-30 2012-03-30 Devices and methods for the treatment of metabolic disorders.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/055795 WO2013143599A1 (en) 2012-03-30 2012-03-30 Devices and methods for the treatment of metabolic disorders.

Publications (1)

Publication Number Publication Date
WO2013143599A1 true WO2013143599A1 (en) 2013-10-03

Family

ID=45926561

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/055795 WO2013143599A1 (en) 2012-03-30 2012-03-30 Devices and methods for the treatment of metabolic disorders.

Country Status (1)

Country Link
WO (1) WO2013143599A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9955914B2 (en) 2013-03-13 2018-05-01 Ethicon Llc Meal detection devices and methods

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292344A (en) * 1992-07-10 1994-03-08 Douglas Donald D Percutaneously placed electrical gastrointestinal pacemaker stimulatory system, sensing system, and pH monitoring system, with optional delivery port
US5345933A (en) * 1991-09-25 1994-09-13 Siemens Aktiengesellschaft Implantable medical device with a protected medication layer
US5690691A (en) * 1996-05-08 1997-11-25 The Center For Innovative Technology Gastro-intestinal pacemaker having phased multi-point stimulation
US6591137B1 (en) * 2000-11-09 2003-07-08 Neuropace, Inc. Implantable neuromuscular stimulator for the treatment of gastrointestinal disorders
US20040092892A1 (en) * 2002-11-01 2004-05-13 Jonathan Kagan Apparatus and methods for treatment of morbid obesity
US20050033331A1 (en) * 2003-07-28 2005-02-10 Polymorfix, Inc., C/O Medventure Associates Pyloric valve obstructing devices and methods
US20050090873A1 (en) * 2003-10-22 2005-04-28 Imran Mir A. Gastrointestinal stimulation device
US20060247721A1 (en) * 2005-04-29 2006-11-02 Cyberonics, Inc. Identification of electrodes for nerve stimulation in the treatment of eating disorders
US20070016262A1 (en) * 2005-07-13 2007-01-18 Betastim, Ltd. Gi and pancreatic device for treating obesity and diabetes
US20070161851A1 (en) * 2004-09-08 2007-07-12 Olympus Corporation Capsulu type medical device
US20070219608A1 (en) * 2006-03-16 2007-09-20 Swoyer John M High efficiency neurostimulation lead
US20070293885A1 (en) * 2004-02-26 2007-12-20 Binmoeller Kenneth F Methods and devices to curb appetite and/or to reduce food intake
US20080195171A1 (en) * 2007-02-13 2008-08-14 Sharma Virender K Method and Apparatus for Electrical Stimulation of the Pancreatico-Biliary System
US20100056948A1 (en) 2008-08-26 2010-03-04 Hornby Pamela J Stimulation of Satiety Hormone Release
US20110270344A1 (en) * 2003-02-03 2011-11-03 Enteromedics Inc. Bulimia treatment

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5345933A (en) * 1991-09-25 1994-09-13 Siemens Aktiengesellschaft Implantable medical device with a protected medication layer
US5292344A (en) * 1992-07-10 1994-03-08 Douglas Donald D Percutaneously placed electrical gastrointestinal pacemaker stimulatory system, sensing system, and pH monitoring system, with optional delivery port
US5690691A (en) * 1996-05-08 1997-11-25 The Center For Innovative Technology Gastro-intestinal pacemaker having phased multi-point stimulation
US6591137B1 (en) * 2000-11-09 2003-07-08 Neuropace, Inc. Implantable neuromuscular stimulator for the treatment of gastrointestinal disorders
US20040092892A1 (en) * 2002-11-01 2004-05-13 Jonathan Kagan Apparatus and methods for treatment of morbid obesity
US20110270344A1 (en) * 2003-02-03 2011-11-03 Enteromedics Inc. Bulimia treatment
US20050033331A1 (en) * 2003-07-28 2005-02-10 Polymorfix, Inc., C/O Medventure Associates Pyloric valve obstructing devices and methods
US20050090873A1 (en) * 2003-10-22 2005-04-28 Imran Mir A. Gastrointestinal stimulation device
US20070293885A1 (en) * 2004-02-26 2007-12-20 Binmoeller Kenneth F Methods and devices to curb appetite and/or to reduce food intake
US20070161851A1 (en) * 2004-09-08 2007-07-12 Olympus Corporation Capsulu type medical device
US20060247721A1 (en) * 2005-04-29 2006-11-02 Cyberonics, Inc. Identification of electrodes for nerve stimulation in the treatment of eating disorders
US20070016262A1 (en) * 2005-07-13 2007-01-18 Betastim, Ltd. Gi and pancreatic device for treating obesity and diabetes
US20070219608A1 (en) * 2006-03-16 2007-09-20 Swoyer John M High efficiency neurostimulation lead
US20080195171A1 (en) * 2007-02-13 2008-08-14 Sharma Virender K Method and Apparatus for Electrical Stimulation of the Pancreatico-Biliary System
US20100056948A1 (en) 2008-08-26 2010-03-04 Hornby Pamela J Stimulation of Satiety Hormone Release

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9955914B2 (en) 2013-03-13 2018-05-01 Ethicon Llc Meal detection devices and methods
US10791988B2 (en) 2013-03-13 2020-10-06 Ethicon Llc Meal detection devices and methods

Similar Documents

Publication Publication Date Title
US10953224B2 (en) Devices and methods for the treatment of metabolic disorders
US9037244B2 (en) Method and apparatus for electrical stimulation of the pancreatico-biliary system
US9037245B2 (en) Endoscopic lead implantation method
US7738961B2 (en) Method and apparatus for treatment of the gastrointestinal tract
US8543210B2 (en) Device and implantation system for electrical stimulation of biological systems
US20080086180A1 (en) Techniques for gall bladder stimulation
US20070255336A1 (en) Gastric constriction device with selectable electrode combinations
US20120277619A1 (en) Detecting food intake based on impedance
KR20180023966A (en) Devices for spoof stimulation and its use
JP2009501046A (en) Gastrointestinal and pancreatic devices for treating obesity and diabetes
EP2125076A1 (en) Spray administration of compositions including active agents such as peptides to the gastrointestinal tract
WO2009114008A1 (en) Method and apparatus for treatment of the gastrointestinal tract
WO2006087717A2 (en) Non-immediate effects of therapy
WO2018094207A1 (en) Modular stimulation system for the treatment of gastrointestinal disorders
WO2013143603A1 (en) Devices and methods for the treatment of metabolic disorders
US10603490B2 (en) Temporarily implantable GI sensor and stimulator and related methods
WO2013143599A1 (en) Devices and methods for the treatment of metabolic disorders.
WO2013143600A1 (en) Devices and methods for the treatment of metabolic disorders.
WO2013143609A1 (en) Devices and methods for the treatment of metabolic disorders
Pontikis et al. Innovations in Bariatric Surgery

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12711639

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12711639

Country of ref document: EP

Kind code of ref document: A1